Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.6B
Avg Funding
$62.2M
Global Reach
9
countries

Top Cities for Therapeutics

New York
San Francisco
Redwood City
Waltham
Barcelona
Princeton

Recently Funded Companies

Export
New York, United States

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

$400.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.

$23.7M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

$50.1M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

$40.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.

Feb 2026

Founder Contacts

41,000+ verified contacts

Princeton, United States

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

$85.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.

$64K raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Illkirch, France

Kainova Therapeutics develops small molecules targeting G-coupled protein receptors.

$23.5M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Ditto Bio develops AI-driven therapeutics by harnessing parasite biology to treat autoimmune diseases effectively.

Feb 2026

Founder Contacts

41,000+ verified contacts

Nottingham, United Kingdom

NuVision™ is a biotechnology research and development spin out company from the University of Nottingham

$6.5M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Midi Health provides virtual care for women in midlife, offering clinician support for menopause, hormonal health, and related conditions.

$100.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

$175.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Aachen, Germany

Enua is a wholesale company that produces pharmaceutical-grade medical cannabis products.

$29.6M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Perugia, Italy

Corabea is a healthcare and wellness company that provides clinical care and digital tools for patients dealing with eating disorders.

$772K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Phoenix, United States

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

$60.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

$257.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Seongnam, South Korea

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

$21.9M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.

$11.2M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

$38.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Aarhus, Denmark

Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.

$1.1M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Richmond, United States

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

$115.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Boulder, United States

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

$55.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

$55.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Surrey, Canada

Eyam Health concentrates on the investigation and creation of vaccines for defending against infectious diseases.

$327K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Dortmund, Germany

Qli5 Therapeutics develops a new class of proteasome inhibitors.

$7.2M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Showing 351 to 375 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$62.2M
Total Funding Tracked
$1.6B
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
2 companies$23.7M
2.New York
1 companies$400.0M
3.Redwood City
1 companies$50.1M
4.Waltham
1 companies$40.0M
5.Barcelona
1 companiesUndisclosed

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked